Recombinant Anopheles gambiae Anamorsin homolog (AGAP008883)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order notes.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for specific delivery timelines.
Note: All proteins are shipped with standard blue ice packs unless dry ice is specifically requested in advance. Additional charges apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
AGAP008883Anamorsin homolog; Fe-S cluster assembly protein DRE2 homolog
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-254
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Anopheles gambiae (African malaria mosquito)
Target Names
AGAP008883
Target Protein Sequence
MNFVQENNHV LYLWAGTVGP EIEQEVNAIK TIPNVQVNVE NVERLQLAEY GKSQFDVILA QVATGNSTLV TLLVKLLKPK GKCVFRDDSA ASIEQARSNL LLAGFINIVA SDSNVYVAEK PDYEVGSKSK LSFAKKSNVA AVWKLDDNEE EERIDDEELL DEDDKAKPTE ESLRVCGTTG KRKACKDCSC GLAEELDAEA KGKALTDTSA AKSSCGSCYL GDAFRCATCP YLGMPAFKPG EKIVLTDTQM QADI
Uniprot No.

Target Background

Function
Anamorsin homolog (AGAP008883) is a component of the cytosolic iron-sulfur (Fe-S) protein assembly (CIA) machinery. It is essential for the maturation of extramitochondrial Fe-S proteins. It functions within an electron transfer chain during an early step of cytosolic Fe-S biogenesis, facilitating the de novo assembly of a [4Fe-4S] cluster on the cytosolic Fe-S scaffold complex. Electrons are transferred from NADPH via a FAD- and FMN-containing diflavin oxidoreductase. In conjunction with this oxidoreductase, Anamorsin is also involved in the assembly of the diferric tyrosyl radical cofactor of ribonucleotide reductase (RNR), likely by providing reducing electrons during radical cofactor maturation in the catalytic small subunit.
Database Links
Protein Families
Anamorsin family
Subcellular Location
Cytoplasm. Mitochondrion intermembrane space.

Q&A

What is the functional role of Anamorsin homolog (AGAP008883) in Anopheles gambiae?

Anamorsin homolog (AGAP008883) in Anopheles gambiae functions as a component of the cytosolic iron-sulfur (Fe-S) protein assembly (CIA) machinery. The protein is required for the maturation of extramitochondrial Fe-S proteins and acts as part of an electron transfer chain during an early step of cytosolic Fe-S biogenesis, facilitating the de novo assembly of [4Fe-4S] clusters on the cytosolic Fe-S scaffold complex . Together with a diflavin oxidoreductase, it contributes to the assembly of the diferric tyrosyl radical cofactor of ribonucleotide reductase (RNR), likely by providing electrons for reduction during radical cofactor maturation in the catalytic small subunit.

Similar to its homologs in other organisms, AGAP008883 likely plays a critical role in cellular iron homeostasis and oxidative stress responses, which may be particularly relevant to understanding the vector biology of A. gambiae in relation to Plasmodium infection and transmission.

What are the optimal expression systems for producing recombinant AGAP008883 protein?

Based on research experiences with recombinant A. gambiae proteins, multiple expression systems have been successfully employed for AGAP008883, each with specific advantages:

Expression SystemAdvantagesLimitationsYieldApplications
E. coliHigh yield, cost-effective, rapid productionLimited post-translational modifications, potential for inclusion bodies10-20 mg/LStructural studies, antibody production
Yeast (K. lactis)Better protein folding, some post-translational modificationsLower yield than E. coli, longer production time2-5 mg/LFunctional assays, protein-protein interaction studies
BaculovirusInsect-specific post-translational modifications, proper foldingHigher cost, technical complexity1-10 mg/LEnzymatic assays, structural biology
Mammalian cellMost complete post-translational modificationsHighest cost, lowest yield, complex protocols0.5-2 mg/LIn vitro activity assays requiring native conformation

For most applications, bacterial expression in E. coli remains the method of choice, particularly when followed by solubilization from inclusion bodies using established protocols . For functional studies where proper folding and post-translational modifications are critical, insect cell expression systems may be more appropriate.

The protein should be expressed with appropriate purification tags (His, GST, or MBP) and purified using affinity chromatography followed by size exclusion chromatography to obtain high purity preparations suitable for downstream applications .

What are the key considerations for designing experiments to study AGAP008883 function in vivo?

When designing experiments to study AGAP008883 function in vivo, several methodological approaches should be considered:

RNA Interference (RNAi) Approach:

  • Design sequence-specific dsRNA targeting AGAP008883

  • Validate knockdown efficiency using RT-PCR and Western blot

  • Assess phenotypic effects on iron homeostasis, oxidative stress response, and potential impact on vector competence

  • Include appropriate controls (non-targeting dsRNA) and time-course analysis (knockdown typically peaks 2-7 days post-injection)

CRISPR-Cas9 Gene Editing:

  • Design guide RNAs specific to AGAP008883 with minimal off-target effects

  • Implement the GAL4/UAS system for conditional expression/knockdown

  • Include molecular verification of editing through sequencing

  • Monitor fitness parameters in modified mosquitoes

Transgenic Overexpression:

  • Utilize the GAL4/UAS system for tissue-specific expression

  • Design constructs with tissue-specific promoters (midgut, salivary gland, fat body)

  • Implement xenotransgenic approaches for cross-species validation

  • Verify expression levels through qPCR and protein quantification

Experimental Controls:

  • Include proper controls for mosquito age, rearing conditions, and genetic background

  • Design experiments with appropriate replication (minimum n=30 per condition)

  • Implement blinding when assessing phenotypes

  • Consider genetic background effects when using different A. gambiae strains

A comprehensive experimental design should incorporate multiple complementary approaches to fully elucidate AGAP008883 function in the context of mosquito biology and vector competence.

How should researchers design experiments to investigate the role of AGAP008883 in iron metabolism of A. gambiae?

Investigating AGAP008883's role in iron metabolism requires a multifaceted experimental approach:

1. Dietary Iron Manipulation Studies:

  • Design feeding regimens with controlled iron concentrations (deficient, normal, excess)

  • Monitor AGAP008883 expression levels in response to dietary changes using qRT-PCR

  • Measure iron content in tissues using ferrozine assay or ICP-MS

  • Assess expression of iron regulatory genes (ferritin, transferrin) as controls

2. Blood Meal Response Analysis:

  • Compare AGAP008883 expression before and after blood feeding at multiple time points (3h, 24h, 48h post-feeding)

  • Correlate with heme metabolism genes and oxidative stress markers

  • Include sugar-fed controls to distinguish blood-specific effects

  • Design follows established protocols for blood-meal studies

3. Knockdown Impact Assessment:

  • Implement RNAi-mediated silencing of AGAP008883

  • Measure iron distribution using Prussian blue staining or ferrozine assay

  • Assess impact on Fe-S cluster containing enzymes (aconitase, xanthine oxidase)

  • Evaluate oxidative stress markers (lipid peroxidation, protein carbonylation)

4. Protein-Protein Interaction Studies:

  • Identify binding partners using co-immunoprecipitation followed by mass spectrometry

  • Validate interactions with known CIA components using pull-down assays

  • Map interaction domains through truncation mutants

  • Quantify binding affinities using surface plasmon resonance

For statistical analysis, implement ANOVA for multi-condition comparisons with post-hoc Tukey's test, and use appropriate non-parametric tests when data doesn't meet normality assumptions. Sample sizes should be calculated based on preliminary data to achieve statistical power of at least 0.8.

What are the best approaches for optimizing experimental design when testing AGAP008883 interactions with other proteins?

Optimizing experimental design for protein interaction studies with AGAP008883 requires careful consideration of multiple factors:

In Vitro Approaches:

  • Yeast Two-Hybrid Screening

    • Construct bait plasmids containing full-length and domain-specific fragments of AGAP008883

    • Screen against A. gambiae cDNA libraries

    • Include appropriate controls (empty vectors, known interactors)

    • Validate positive hits with secondary assays

  • Pull-Down Assays

    • Express recombinant AGAP008883 with different tags (His, GST, MBP)

    • Use mosquito tissue lysates as prey

    • Implement stringent washing conditions to minimize false positives

    • Confirm results with reverse pull-downs using identified partners

  • Surface Plasmon Resonance

    • Immobilize purified AGAP008883 on sensor chips

    • Test binding kinetics with purified candidate partners

    • Determine association/dissociation constants

    • Evaluate effects of oxidation state and Fe-S cluster presence

In Vivo Approaches:

  • Co-Immunoprecipitation

    • Generate specific antibodies against AGAP008883

    • Prepare tissue lysates under native conditions

    • Include appropriate negative controls (pre-immune serum, non-relevant antibodies)

    • Confirm reciprocal co-IPs with partner antibodies

  • Proximity Ligation Assay

    • Design specific antibodies for AGAP008883 and candidate partners

    • Visualize interactions in situ in mosquito tissues

    • Quantify interaction signals across different tissues and conditions

Experimental Design Considerations:

  • Use factorial design to test multiple variables (protein concentration, buffer conditions, temperature)

  • Include biological replicates (minimum n=3) for each condition

  • Implement positive and negative controls for each experiment

  • Consider the natural oxidation state of the protein when designing buffer systems

Following these methodological approaches will maximize the likelihood of detecting authentic protein interactions while minimizing false positives and artifacts.

How can researchers distinguish between direct and indirect effects when studying AGAP008883's role in oxidative stress response?

Distinguishing between direct and indirect effects of AGAP008883 in oxidative stress response requires sophisticated experimental design and careful controls:

1. Temporal Analysis Design:

  • Implement time-course experiments following AGAP008883 knockdown or overexpression

  • Monitor oxidative stress markers at short intervals (1h, 3h, 6h, 12h, 24h)

  • Graph temporal relationships between AGAP008883 levels and downstream effects

  • Primary effects typically manifest earlier than secondary consequences

2. Dose-Response Relationship Analysis:

  • Create mosquito lines with varying levels of AGAP008883 expression (RNAi with different efficiencies or inducible expression systems)

  • Measure correlation between AGAP008883 levels and oxidative stress parameters

  • Direct effects typically show stronger dose-response relationships than indirect effects

  • Fit data to appropriate mathematical models (linear, sigmoidal, etc.)

3. Pathway Inhibition Strategy:

  • Selectively inhibit potential intermediate pathways

  • If AGAP008883 effects persist despite pathway inhibition, direct action is supported

  • If effects are blocked, the inhibited pathway likely mediates AGAP008883 action

  • Include appropriate pharmacological controls

4. Reconstitution Experiments:

  • Purify recombinant AGAP008883 protein

  • Test direct effects in cell-free systems with isolated cellular components

  • Design in vitro assays measuring specific activities (Fe-S transfer, ROS scavenging)

  • Compare with known direct-acting antioxidant proteins

5. Protein Domain Mutation Analysis:

  • Generate AGAP008883 variants with mutations in functional domains

  • Test which domains are required for oxidative stress protection

  • Correlate specific biochemical activities with stress response phenotypes

  • Design mutations that separate Fe-S assembly function from other potential roles

Implementing these approaches in combination provides robust evidence to distinguish direct from indirect effects, critical for accurately defining AGAP008883's role in mosquito oxidative stress response.

What methodological approaches are most effective for studying AGAP008883's potential involvement in vector competence for Plasmodium?

Investigating AGAP008883's potential role in vector competence requires integrated approaches spanning molecular, cellular, and organismal levels:

1. Infection Studies with Gene Manipulation:

  • Generate AGAP008883 knockdown and overexpression mosquitoes

  • Challenge with Plasmodium berghei (rodent model) and P. falciparum (human parasite)

  • Measure infection parameters:

    • Oocyst prevalence and intensity

    • Sporozoite loads in salivary glands

    • Transmission efficiency to naive hosts

  • Include appropriate controls (age-matched, same genetic background)

2. Tissue-Specific and Temporal Expression Analysis:

  • Design tissue-specific knockdown using the GAL4/UAS system

  • Target expression modification in midgut, hemocytes, and salivary glands

  • Implement blood-meal inducible promoters for temporal control

  • Measure tissue-specific effects on parasite development stages

3. Molecular Pathway Analysis:

  • Perform transcriptomic analysis comparing wild-type and AGAP008883-modified mosquitoes during infection

  • Identify differentially expressed immune genes

  • Measure oxidative stress parameters during infection progression

  • Assess iron distribution in tissues during infection

4. Biochemical Interaction Studies:

  • Test direct interaction between purified AGAP008883 and Plasmodium proteins

  • Investigate AGAP008883 localization during infection using immunofluorescence

  • Determine if Plasmodium infection alters AGAP008883 expression or activity

  • Measure parasite iron acquisition in the presence/absence of AGAP008883

5. Field-Relevant Approaches:

  • Test multiple A. gambiae strains with different genetic backgrounds

  • Include environmental variables (temperature, humidity) in experimental design

  • Consider microbiome interactions through controlled colonization experiments

  • Validate laboratory findings with field-derived mosquito populations

This comprehensive approach will provide robust evidence for AGAP008883's potential role in vector competence while accounting for biological variability and environmental factors relevant to disease transmission dynamics.

How should researchers address potential confounding factors when analyzing the phenotypic effects of AGAP008883 modification?

1. Genetic Background Control:

  • Use isogenic lines when performing genetic modifications

  • Backcross modified lines to parental strain for at least 5 generations

  • Include multiple independent transgenic/knockdown lines in analysis

  • Implement appropriate genetic controls (e.g., non-targeting RNAi, empty vector transgenics)

2. Off-Target Effect Mitigation:

  • Design multiple RNAi constructs targeting different regions of AGAP008883

  • Validate specificity through transcriptome analysis

  • Perform rescue experiments with RNAi-resistant transgenes

  • Use CRISPR-Cas9 with multiple guide RNAs to confirm phenotypes

3. Life History Trait Assessment:

  • Comprehensively measure:

    • Development time

    • Adult longevity

    • Reproductive output

    • Blood-feeding behavior

    • General fitness parameters

  • Determine if phenotypes are specific or result from general health impairment

4. Environmental Variable Control:

  • Standardize:

    • Rearing temperature (27±1°C)

    • Humidity (75±5%)

    • Photoperiod (12:12 light:dark)

    • Diet composition and feeding regimen

    • Experimental timing relative to mosquito age

  • Include environmental measurements as covariates in statistical models

5. Statistical Approaches for Confounding Control:

  • Implement factorial designs to test interaction effects

  • Use multivariate analysis to control for correlated variables

  • Apply propensity score matching when randomization is imperfect

  • Perform sensitivity analysis to test robustness of findings

6. Reporting and Transparency:

  • Document all experimental conditions in detail

  • Report negative and inconclusive results

  • Include comprehensive methods for replication

  • Share raw data in public repositories

By systematically addressing these potential confounding factors, researchers can substantially increase confidence that observed phenotypes are specifically attributable to AGAP008883 modification rather than experimental artifacts or secondary effects.

What are the most effective approaches for studying post-translational modifications of recombinant AGAP008883?

Post-translational modifications (PTMs) of AGAP008883 are likely critical for its function in Fe-S cluster assembly. The following methodological approaches are recommended for comprehensive PTM analysis:

1. Mass Spectrometry-Based Approaches:

  • Implement bottom-up proteomics with tryptic digestion

  • Use complementary fragmentation methods (CID, ETD, HCD) for comprehensive coverage

  • Apply titanium dioxide enrichment for phosphorylation analysis

  • Utilize HILIC fractionation for glycopeptide enrichment

  • Employ targeted MRM for quantitative analysis of specific modifications

Sample Preparation Considerations:

  • Extract protein under non-reducing conditions to preserve disulfide bonds

  • Use multiple proteases (trypsin, chymotrypsin, AspN) for improved sequence coverage

  • Include phosphatase inhibitors to preserve phosphorylation states

  • Minimize oxidation during sample handling with argon overlay

2. Site-Directed Mutagenesis Strategy:

  • Identify putative PTM sites through bioinformatic prediction and MS validation

  • Generate site-specific mutants (S→A for phosphorylation, C→S for disulfide bonds)

  • Compare functional activity of wild-type and mutant proteins

  • Create comprehensive mutation panels to assess combinatorial effects

3. Specific PTM Analysis Methods:

PTM TypeDetection MethodQuantification ApproachFunctional Validation
PhosphorylationPhos-tag SDS-PAGE, ProQ Diamond stainingSILAC/TMT labeling, MRMPhosphomimetic mutations (S→D/E)
Disulfide bondsNon-reducing SDS-PAGE, Diagonal electrophoresisMS with differential alkylationC→S mutations, reduction sensitivity
Fe-S coordinationUV-vis spectroscopy, EPRIron quantification, Mössbauer spectroscopyLigand mutations, reconstitution assays
GlycosylationLectin blotting, PNGase F treatmentHILIC-MSTunicamycin treatment, N→Q mutations

4. Expression System Selection for PTM Studies:

  • Use insect cell expression systems (Sf9, High Five) for most authentic PTM profiles

  • Compare modifications across expression systems to identify critical PTMs

  • Consider native purification from A. gambiae as reference standard

  • Implement in vitro modification with recombinant enzymes for mechanistic studies

These methodological approaches will provide comprehensive insights into the PTM landscape of AGAP008883 and their functional significance in mosquito biology.

What are the methodological challenges in comparing AGAP008883 function between insecticide-resistant and susceptible Anopheles strains?

Investigating AGAP008883 function across insecticide-resistant and susceptible Anopheles strains presents specific methodological challenges that require careful experimental design:

1. Genetic Background Variability:

  • Challenge: Resistant and susceptible strains often differ in multiple genetic loci beyond resistance genes

  • Solution: Create near-isogenic lines through backcrossing resistant strains to susceptible backgrounds

  • Methodology: Implement at least 5-10 generations of backcrossing with molecular marker selection

  • Validation: Confirm genetic similarity through whole-genome sequencing or SNP panel analysis

2. Resistance Mechanism Heterogeneity:

  • Challenge: Different resistance mechanisms (target-site, metabolic, cuticular) may interact differently with AGAP008883 function

  • Solution: Characterize specific resistance mechanisms in each strain using bioassays and molecular diagnostics

  • Methodology: Implement WHO tube assays, biochemical assays for enzyme activity, and molecular genotyping for kdr, rdl, and ace-1 mutations

  • Analysis: Stratify results by resistance mechanism type and intensity

3. Tissue-Specific Expression Differences:

  • Challenge: Resistance may alter tissue-specific expression patterns of multiple genes

  • Solution: Implement tissue-specific transcriptomic and proteomic profiling

  • Methodology: Use tissue microdissection followed by qRT-PCR or RNA-Seq for expression analysis

  • Controls: Include housekeeping genes with stable expression across resistant and susceptible strains

4. Physiological State Standardization:

  • Challenge: Resistant mosquitoes may differ in life history traits affecting experimental outcomes

  • Solution: Standardize age, feeding status, and physiological condition

  • Methodology: Use tightly synchronized cohorts, controlled feeding protocols, and standardized rearing conditions

  • Measurements: Monitor key physiological parameters (body size, weight, nutritional reserves)

5. Interaction with Resistance-Conferring Proteins:

  • Challenge: Resistance proteins (e.g., P450s, GSTs) may functionally interact with AGAP008883

  • Solution: Implement protein-protein interaction studies comparing resistant and susceptible variants

  • Methodology: Use co-immunoprecipitation, proximity ligation assays, and yeast two-hybrid screens

  • Validation: Confirm interactions through in vitro reconstitution with purified components

6. Data Analysis and Interpretation Frameworks:

  • Challenge: Complex interactions between resistance status and AGAP008883 function

  • Solution: Implement multifactorial experimental designs and appropriate statistical models

  • Methodology: Use mixed-effects models incorporating resistance status, genetic background, and environmental factors as variables

  • Validation: Perform independent validation in multiple strain comparisons

Addressing these methodological challenges systematically will enable robust comparisons of AGAP008883 function between resistant and susceptible strains, potentially revealing novel connections between iron metabolism and insecticide resistance mechanisms.

How can researchers effectively design experiments to study the interaction between AGAP008883 and the mosquito immune system during Plasmodium infection?

Designing experiments to investigate AGAP008883's interaction with the immune system during Plasmodium infection requires an integrated approach:

1. Temporal Immune Response Profiling:

  • Design time-course experiments sampling at key infection stages (3h, 24h, 3d, 7d, 14d post-infection)

  • Measure AGAP008883 expression alongside immune genes (TEP1, LRIM1, APL1C)

  • Implement both qRT-PCR for targeted analysis and RNA-Seq for global profiling

  • Compare patterns between susceptible and refractory mosquito strains

2. Immune Pathway Manipulation:

  • Perform dual knockdown experiments (AGAP008883 + key immune factors)

  • Assess epistatic relationships through phenotypic analysis

  • Focus on complement-like pathways involving TEP1, which is known to function with LRIM1/APL1C

  • Implement pathway-specific genetic manipulations using the GAL4/UAS system

3. Hemolymph Proteome Analysis:

  • Collect hemolymph at defined time points post-infection

  • Compare proteome profiles between wild-type and AGAP008883-modified mosquitoes

  • Identify changes in circulating immune factors

  • Quantify levels of iron-binding proteins and oxidative stress markers

4. Cellular Immune Response Assessment:

  • Analyze hemocyte numbers and types using flow cytometry

  • Measure phagocytic activity toward Plasmodium and model particles

  • Assess hemocyte-specific gene expression with single-cell RNA-Seq

  • Determine if AGAP008883 affects hemocyte differentiation or function

5. Oxidative Burst Measurement:

  • Design assays to quantify ROS production during infection

  • Compare oxidative response between control and AGAP008883-modified mosquitoes

  • Implement fluorescent probes for in vivo ROS visualization

  • Correlate oxidative burst intensity with parasite survival

6. Iron Homeostasis and Immune Function:

  • Manipulate dietary iron levels in combination with AGAP008883 modification

  • Measure impact on complement activation and melanization responses

  • Assess iron sequestration as an nutritional immunity mechanism

  • Determine if AGAP008883 mediates iron-dependent immune effector functions

Methodological Controls and Considerations:

  • Include appropriate genetic background controls

  • Implement parallel experiments with multiple Plasmodium species (P. berghei, P. falciparum)

  • Control for infection intensity through standardized feeding protocols

  • Consider environmental variables (temperature, microbiota) known to affect immune function

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.